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Abstract
Genome wide association studies (GWAS) and their replications that have associated DNA variants with myocardial
infarction (MI) and/or coronary artery disease (CAD) are predominantly based on populations of European or Eastern Asian
descent. Replication of the most significantly associated polymorphisms in multiple populations with distinctive genetic
backgrounds and lifestyles is crucial to the understanding of the pathophysiology of a multifactorial disease like CAD. We
have used our Lebanese cohort to perform a replication study of nine previously identified CAD/MI susceptibility loci (LTA,
CDKN2A-CDKN2B, CELSR2-PSRC1-SORT1, CXCL12, MTHFD1L, WDR12, PCSK9, SH2B3, and SLC22A3), and 88 genes in related
phenotypes. The study was conducted on 2,002 patients with detailed demographic, clinical characteristics, and cardiac
catheterization results. One marker, rs6922269,i nMTHFD1L was significantly protective against MI (OR=0.68, p=0.0035),
while the variant rs4977574 in CDKN2A-CDKN2B was significantly associated with MI (OR=1.33, p=0.0086). Associations
were detected after adjustment for family history of CAD, gender, hypertension, hyperlipidemia, diabetes, and smoking. The
parallel study of 88 previously published genes in related phenotypes encompassed 20,225 markers, three quarters of which
with imputed genotypes The study was based on our genome-wide genotype data set, with imputation across the whole
genome to HapMap II release 22 using HapMap CEU population as a reference. Analysis was conducted on both the
genotyped and imputed variants in the 88 regions covering selected genes. This approach replicated HNRNPA3P1-CXCL12
association with CAD and identified new significant associations of CDKAL1, ST6GAL1, and PTPRD with CAD. Our study
provides evidence for the importance of the multifactorial aspect of CAD/MI and describes genes predisposing to their
etiology.
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Introduction
Given increased life expectancy, prevention of diseases with
severe manifestations and later life complications has become of tre-
mendous importance. Researchers’ interest in identifying coronary
artery disease (CAD) susceptibility genes reflects the very high
mortality associated with both the disease [1] and one of its most
serious complications: myocardial infarction (MI). While identifying
the primary causes of CAD has been complicated by the multi-
factorial nature of the disease, genome-wide association studies
(GWAS) have been moderately successful in revealing some of the
polygenic structure of CAD. However, they only explain a modest
fraction of the total heritability of CAD [2,3].
Linkage disequilibrium is the primary mechanism for generat-
ing direct (causal) and indirect (non-causal) genetic associations.
Population stratification following population mixing [4,5] can
lead to large numbers of correlated mutations [5,6,7], almost all of
which are expected to be non-causal [8]. Population effects may
also produce strong associations in some populations but not
others by means of specific enrichment due to population genetic
effects (e.g. drift and founder effect) [4,5,9,10]. Furthermore, in
view of the multifactorial nature of CAD, the effects of genes
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tions but not in others depending on diet, lifestyle, and genetic
background. Recent GWAS and their replications that have
established highly significant associations of variants with MI and/
or CAD are predominantly based on populations of European
[11,12,13], Eastern Asian [11,14,15], and more recently, South
Asian descent [16]. Replication of these results for the most
significantly associated polymorphisms in multiple populations
with distinguishing genetic and lifestyle backgrounds is crucial in
isolating the pathophysiology of a multifactorial disease like CAD.
Here, in complement to a GWAS performed for MI and CAD
on the same subjects, we have sought to perform a replication
study in a Middle-Eastern population of SNPs identified in GWAS
of other populations. We have selected susceptibility loci based on
prior studies to confirm the association of 10 recently identified
SNPs at nine independent loci (Table 1) associated with increased
risk of CAD and/or MI in 4 major GWAS conducted in
populations of European [11,12,13] and East Asian ancestry
[11,14]. In parallel, we have assessed association with CAD
phenotype at 88 genes associated with related phenotype using
patterns of correlation among SNPs from the International
HapMap project around 4,784 genotyped SNPs from these
candidate regions to impute genotype at 15,441 collocated, but
unavailable marker.
Materials and Methods
Study Subjects
A total of 2,002 subjects recruited between 2006 and 2009 for
inclusion in the FGENTCARD database (www.well.ox.ac.uk/
fgentcard) were selected. These subjects were referred to a catheter-
ization care unit for clinical evaluation. The 4 main coronary
arteries: the left main artery (LMCA), the left anterior descending
artery (LAD), the left circumflex artery (LCx), and the right
coronary artery (RCA) were visualized from different angles by
angiography. The extent of stenosis in these vessels was assessed and
recordedbypercentage.Someofthesepatientswereadmittedtothe
hospital for having an MI as diagnosed by electrocardiogram and
high troponin levels. Cardiologists performing the coronary
angiography collected a 20 mL blood sample from the peripheral
femoral artery of patients who provided a written consent for the
whole study including the genetic analysis. Blood chemistry metrics
were obtained. Trained healthcare professionals collected further
data on the socio-demographic background of the patients.
Annotations were coded from medical charts according to our
study protocol, which included results of any additional data such as
laboratory tests, prescribed medications, and presence of other
diseases and conditions. Physician classified a patient as dyslipi-
demic when LDL.130 mg/dl and HDL,40 mg/dl, diabetic (type
2) if fasting glucose level.125 mg/dl, hypertensive when blood
pressure was .10/14 mm Hg. A positive family history was
defined as a sibling, parent, or second-degree relative with a
coronary event.
Genomic DNA was extracted using a standard phenol extrac-
tion protocol. Genotyping was performed on Illumina Human610-
Quad and Illumina Human660W-Quad BeadChips, at the Centre
National de Ge ´notypage, France. Out of the 2,002 genomic DNA
samples analyzed, 1,949 non-duplicated samples with quality
filtered genotyping data were retained. After the removal of three
individuals with genotyping success rate less than 95% and 19
pairs of individuals which were suspected to have been duplicated,
1,949 individuals with quality filtered genotyping data were
retained. Genotyping success rate was more than 98%, minor
allele frequency more than 1%, and the p value of Hardy-
Weinberg equilibrium test was less than 1610
27. The Institutional
Review Board at the Lebanese American University approved the
study protocol.
Statistical analyses of the nine candidate loci
Our study is a retrospective cross-sectional design with subjects
drawn from catheterized patients. Two clinical outcomes were
considered in this phase of the study: coronary artery stenosis and
MI. In the coronary artery stenosis outcome, subjects were
categorized as those with no sign of stenosis (‘‘super-controls’’,
CAD category 1, n=425), whereas cases were patients categorized
into two classes [17] CAD category 2 for patients with stenosis of
less than 50% in at least one vessel (n=214), and CAD category 3
for patients with stenosis greater than 50% in at least one vessel
diagnosed by catheterization (n=1,310). MI diagnosis was
established based on medical examination upon admission to the
hospital. In the MI outcome, cases were patients admitted to the
hospital with MI positive (n=222) whereas controls (n=1,727)
were patients admitted for reasons other than MI, such as unstable
angina or cardiac diagnostic workup.
Table 1. Description of the 10 SNPs used in the study.
Chr / rs Gene Association with Risk allele Population site Reference
6p21 / rs1041981 LTA MI A Japan Ozaki et al., 2002
9p21 / rs4977574 CDKN2A-CDKN2B MI G Italy Kathiresan et al., 2009
1p13 / rs646776 CELSR2-PSRC1-SORT1 MI T US Kathiresan et al., 2009
1q41 / rs1746048 CXCL12 MI C Spain Kathiresan et al., 2009
6q25 / rs6922269 MTHFD1L MI A Finland Kathiresan et al., 2009
2q33 / rs6725887 WDR12 MI C Sweden Kathiresan et al., 2009
1p32 / rs11206510 PCSK9 MI T Kathiresan et al., 2009
12q24 / rs3184504 SH2B3 MI T Iceland Europe Gudbjartsson et al., 2009
12q24 / rs653178 SH2B3 MI C Asia Gudbjartsson et al., 2009
6q26-27 / rs2048327 SLC22A3 CAD C Britain Germany Tre ´goue ¨t et al., 2009
For each SNP, genomic location, gene site, association with CAD and/or MI, risk allele, and populations in which association was found are displayed in left to right
columns. For each association study, reference is indicated.
Abbreviations: Chr, chromosome; SNP, single nucleotide polymorphism; MI, myocardial infarction; CAD, coronary artery disease.
doi:10.1371/journal.pone.0029427.t001
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artery. We determined the Chi-squared significance for categorical
variables: gender, presence of diabetes mellitus, hypertension,
smoking, and family history of CAD, and Welch t-test for con-
tinuous variables: FBG, total cholesterol, HDL, LDL, triglycerides,
age, and body mass index (BMI). Categorical variables were
summarized as percentages while continuous variables with para-
metric distributions were summarized as means and standard
deviations. Age of onset was expressed as median and interquartile
range (IQR) and triglyceride levels were logarithmically scaled
before analysis (Table 2). Statistical differences between controls
and cases for these risk factorswereassessed usingthe unpaired two-
sided t-test for the continuous variables and the chi-square test for
categorical variables (Table 2).
The 10 SNPs analyzed (Table 1) were selected based on their
association with CAD/MI and were searched for using the NCBI
PubMed Entrez database (http://www.ncbi.nlm.nih.gov/sites/
gquery). The association of each SNP with CAD and/or MI
was assessed in genotypic and allelic association models using
logistic regression.
Proportional odds logistic regression was performed across CAD
categories, and standard logistic regression was performed on MI
cases vs. controls. The candidate risk alleles were categorized as
absent (allele score=0), heterozygous (allele score=1), and
homozygous (allele score=2). Logistic regression analyses treated
the allele score linearly, corresponding to treating the genotype
heterozygous vs. homozygous states as additive to risk, and in
separate analyses, treating each allele score as distinct risk
categories. Regressions were performed for unadjusted risk odds
ratio estimates, as well as adjusted analyses for family history of
CAD, gender, hypertension, hyperlipidemia, diabetes, and
smoking.
Imputation-based analysis of candidate genes
Coronary artery stenosis was the only clinical outcome
considered in this phase of the study. A total of 20,225 variants
located in 88 different genes were tested for association in our
Lebanese CAD cohort using imputation-based analysis. SNPs
were selected on the basis of MI/CAD phenotype in NCBI
Phenotype-Genotype Integrator (PheGenI) (http://www.ncbi.nlm.
nih.gov/gap/PheGenI#pgGAP) and on literature review
[16,18,19,20]. Imputation utilizes theLebanese population genotype
data from 4,784 SNPs, in combination with haplotype information
from the CEU population of the release 22 of HapMap to predict
genotypes of 15,441 nearby SNPs not genotyped in our subjects.
Although the Principal Component Analysis identified our cohort to
be closest to the HapMap CEU (data not shown), some underlying
different genetic background with the discovery cohorts may exist.
We therefore tested for association across the corresponding 88
genes rather than individual variants (Table S1). After imputing
across the whole genome to HapMap CEU reference population
using Impute v2 [21], we selected both the genotyped and imputed
variants inthe 88 regionscovering the selected genes, allowing for an
extra 50 Kb on either side. Because of the probabilistic nature of the
genotypes inferred by imputation, we applied SNPTest2 to perform
an additive association test using a missing data likelihood score
("-frequentist 1 -method score"), including age and sex as covariates
[22]. Effect and significance were reported for association with
p-value,0.01 and marker with info.0.4 (Table S1).
Results
Following QC filtering, the sample consisted of 1,949 subjects,
72.7% of whom were males, with a median 6IQR age of 62616
years, and a mean BMI of 29.064.7 kg/m
2. Among these
subjects, 54.6% were hypertensive, 48.0% were hyperlipidemic,
61.8% had a family history of CAD (parents or siblings), and
29.7% were diabetic. Moreover, higher prevalence among cases
compared to controls of diabetes, hypertension, hyperlipidemia,
family history of CAD, raised glucose levels, and reduced HDL
levels, were observed (Table 2).
The probability of 2 or fewer successes out of 10 Bernoulli trials
at the 0.05 significance threshold is 0.0861. However, minor allele
frequencies were sufficiently low among a number of SNPs for
cases or controls that information about those specific counts
was compromised. Only the MI test for rs4977574 was significant
after over conservative Bonferroni correction for a one-tail test,
while only the rs6922269 was found significantly protective after
Bonferroni correction for CAD.
Table 2. Distribution of biological and biochemical characteristics of patients by stenosis category (n=1,949).
Total (n=1,949) No stenosis (n=425) Stenosis (n=1,524) p-value
Males (%) 72.7 57 77.1 2.4610
216
Diabetes (%) 29.7 16.2 33.4 9.5610
213
Hypertension (%) 54.6 43 58 4.6610
28
Hyperlipidemia (%) 47.9 36.2 51.2 3.8610
28
Smoking (%) 64.4 55.6 66.9 2.8610
25
Family History of CAD (%) 61.8 65.4 56.1 0.0059
Age of onset (Median ±IQR) -- -- 62 616 --
Glucose (mg/dl) 118.8 642.5 106.9 633.7 122.0 644.1 2.6610
211
Total Cholesterol (mg/dl) 187.1 648.4 187.7 642.2 188.0 649.9 0.925
HDL (mg/dl) 41.3 612.0 42.6 613.0 41.0 611.7 0.029
LDL (mg/dl) 114.2 641.1 114.1 634.2 114.2 642.7 0.95
Log (triglycerides) 5.1 60.5 5.0 60.5 5.1 60.5 0.15
BMI 29.0 64.7 29.4 65.2 28.9 64.6 0.11
Left column lists the risk factors investigated upon recruitment of the study population. Averages values of biochemical characteristics are indicated for each of the total
population, population without stenosis, and population with stenosis. The P-value is the chi-square.
doi:10.1371/journal.pone.0029427.t002
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(k=4), capturing extremes of the leading Lebanese-specific
principal components, did not predict MI or CAD, nor interact
with risk factors or identified risk SNPs in the prediction of CAD
or MI (data not shown). Population stratification identified in the
cohort was shown not to have a significant effect in the association
with a genomic control of l= 1.033 (data not shown).
Risks associated with each allele expressed as odds ratios, odds
ratios adjusted for gender, hypertension, hyperlipidemia, smoking,
and diabetes, are displayed in Table S2 for CAD, and Table S3 for
MI. Eight of the ten SNPs, rs1041981, rs11206510, rs1746048,
rs3184504, rs646776, rs653178, rs6725887, and rs2048327,
showed no two-tailed significant associations with CAD or MI
(Tables S2 and S3).
SNP rs4977574 was not significantly associated with CAD
(Table S2), but was significantly associated with MI in a propor-
tional odds logistic regression (OR=1.86, 95%CI=1.1723.07,
p=0.012) for the GG genotype compared to the AA genotype
(Table S3). In an adjusted analysis, this association with MI was
unaltered (OR=1.84, 95%CI=1.1423.09, p=0.011) (Table S3).
The heterozygous GA genotype vs. AA showed odds ratios of 1.39
(unadjusted) and 1.42 (adjusted), but were insignificant (Table S3).
Allele frequency results were also insignificant contrasting G vs.
A alleles (OR=1.38, 95%CI=1.0121.90, p=0.039). All adjust-
ment risk factors made highly significant contributions to the
proportional odds logistic regression (Table 3).
The variant rs6922269, was seen to be robustly significant as
protective against MI. The heterozygous odds ratio was highly
significant (OR=0.66, 95%CI=0.4820.9, p=0.0087), and re-
mained significant after adjustment (OR=0.63, 95%CI=0.4520.85,
p=0.0037) (Table S3). The additive model risk showed an
OR=0.72, 95%CI=0.5620.91, p=0.0083, and adjusted OR=
0.69, 95%CI=0.5320.88, p=0.0035. It is interesting to note that the
measured OR for the homozygous allele was 0.63, 95%CI=
0.3121.15, p=0.163 before adjustment, and OR=0.60, 95%CI=
0.3021.10, p=0.121 after adjustment, though while as strong as the
heterozygous risk, the error bars were much wider suggesting the
population size of n=11 for MI subjects carrying the homozygous
allele was too small to resolve this risk, also suggestive of a protective
power for the allele.
Analysis of our Illumina data allowed us to query much of the
known SNP variations in the genome. Using an imputation
method as a thorough survey of the variations from 88 genes, a
total of 15,441 SNPs were imputed genotypes in addition to the
4,784 genotyped SNPs. Table S1 presents an overview of the
most nominally significant SNPs (p,0.01) in the regions that have
been reported for CAD. SNPs located in the linked regions of
CDKAL12, ST6GAL1, CXCL12, and PTPRD were the most highly
associated with p values ,0.0009. Rs9295489 in the CDKAL1
locus presented the highest association with CAD (beta coeffi-
cient=0.12, p=0.0004) (Table S1). The locus increased the risk of
CAD of about 1.12. Three imputed SNPs in the 50 Kb block of a
second locus, ST6GAL1, had p values ranging from 0.0007
(rs16861460) to 0.0008 (rs16861471). The locus had a protective
effect against CAD with an estimated beta coefficient of 20.17,
corresponding to an odds ratio of 0.8 (Table S1). A third gene,
CXCL12, was found to play a role in CAD etiology. The SNP
rs7900896 (beta coefficient=0.12, p=0.0008) located in the
CXCL12 LD block gave high relative information about the
additive model and showed significant association with CAD. A
fourth LD region defining the PTPRD locus had one in the top six
hits of our analysis (rs10115782; beta coefficient=0.2, p=0.0009).
It was highly informative and presented significant association with
CAD (Table S1).
Discussion
Replication studies are subject to variations in design adding a
significant level of complication to comparative analysis [23].
Variability in study enrollment, as well as the use of different
inclusion and exclusion criteria such as age of onset, all have the
potential to impact risk estimates [12,24]. Most importantly, CAD
outcomes are classified by varying standards. While some use
coronary angiography to firmly verify the disease status and to
determine whether a patient should belong to the cases or controls
groups, others are considering apparently healthy individuals from
the general population as controls. A major strength of our study
relies on the unambiguous angiographic visualization of CAD
phenotypic characterization. A longitudinal prospective study
sampling the population at large would have been ideal to increase
Table 3. Association of CAD with rs497754 adjusting for each of
gender, hypertension, hyperlipidemia, smoking, and diabetes.
Interactive Risk Adj. OR 95% CI p-value power
Gender (Female as reference) 2.511 (2.00, 3.15) ,0.0001 1.0000
GG 1.403 0.0205
(1.01, 1.94) 0.533
AG 1.269 0.0692
(0.93, 1.74) 0.316
AA
DxHypertension 1.834 ,0.0001
(1.48,2.28) 0.9998
GG 1.423 0.0161
(1.03, 1.96) 0.573
AG 1.252 0.0805
(0.91, 1.71) 0.288
AA
DxHyperlipidemia 1.845 ,0.0001
(1.48, 2.30) 0.9997
GG 1.359 0.0304
(0.98, 1.87) 0.466
AG 1.24 0.0887
(0.91, 1.69) 0.271
AA
Smoking 1.636 ,0.0001
(1.31,2.04) 0.993
GG 1.337 0.0377
(0.97, 1.84) 0.428
AG 1.202 0.124
(0.88, 1.64) 0.21
AA
DxDiabetes 2.466 ,0.0001
(1.87, 3.25) 1.0000
GG 1.402 0.0198
(1.02, 1.93) 0.539
AG 1.228 0.0991
(1.86 3.25) 0.025
AA
Abbreviations: Adj., adjusted; OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0029427.t003
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consequent to low frequency representation. However such
invasive measures of disease would be ethically impossible.
We have found that the variant rs4977574 located within the
9p21 locus confers an increased risk of developing MI in the GG
state. Moreover, subjects homozygous for the G allele are at a
much higher risk of MI. These results are in accordance with a
study by Kathiresan where rs4977574 G allele was shown to be
associated with MI [12]. This study argued that altered transcript
levels of CDKN2B in visceral tissue may increase the risk of
atherosclerosis emergence [12]. It is pertinent to note that since
our study and the GWAS mentioned are all retrospective studies,
the rs4977574 risk was survived by patients in treatment of CAD
and/or MI long enough to be enrolled in the study.
It is of importance to note that the 9p21 locus, in particular
variant rs4977574, did not show genome wide significance for
CAD (p=0.0107) or MI (p=0.00448) when a GWAS was
conducted on this study population (data not shown). This SNP is
within a range consistent with the logistic regression results,
though not significant after over-conservative Bonferroni correc-
tion.
The rs4977574 variant is located within the ANRIL gene that
encodes a large non-coding RNA [25]. While it still needs to be
elucidated, implication of ANRIL in the pathophysiology of
coronary artery syndrome has been strongly supported by
expression studies [26,27,28]. The ANRIL promoter region
contains binding sites for zinc-finger proteins that are critical for
the transcription of CDKN2A and CDKN2B [29]. In the mouse,
deletion of the 9p21 orthologous non-coding region including the
39 region of ANRIL affects proliferation of vascular cells while
expression of CDKN2A and CDKN2B is severely reduced [30] thus
indicating potential implications in the disease etiology in humans.
The variant rs6922269 has shown a protective effect against MI
in our population. Association of this variant was already
characterized by others [31] through analysis of the Wellcome
Trust Case Control Consortium (WTCCC) [32] population.
However this association was not confirmed in the Tunisian
population [33], and functional implications of the gene in CAD
etiology have not been investigated. It can be hypothesized that
the inverse relationship of rs6922269 compared to other studies
suggests significant interactions with other exposure, or an
inverted linkage with the active alleles in the Lebanese population
relative to other populations showing risk.
Noneof the remaining eight gene variants identifiedas significant
CAD or MI risks in other populations showed a contribution to risk
of CAD or MI in the Lebanese population, even though some of
them are implicated as candidates through genetic association
[11,12] and molecular mechanisms [34,35,36,37,38,39]. The
negative results regarding these SNPs are important to consider
since the differences in association across populations could indicate
differences due to lifestyle or environment, or population-specific
mutation interaction factors, or linkage variations mitigating disease
development. For a number of these alleles, low power due to small
numbers,especiallyinthe reference category, mayaccount forsome
of the losses of significance.
High-throughput genotyping chips such as the Illumina 660Hap
used here provide a very good genome-wide coverage via tagSNPs
which best represent the underlying haplotypes. This should allow
for the identification of regions associated with given phenotypes.
However, the tagSNPs provide statistical rather than functional
association. It is therefore important to go beyond the original chip
and look for the causative variant. Despite a potentially lower
MAF, causative variants should have a stronger effect on the
phenotype, and more biological relevance. Furthermore, in the
case of replication of association originally observed in Caucasian,
it is possible that the reported SNP is not associated in our
Lebanese cohort. Since our population is sufficiently closely
related to the CEU, we could use HapMap catalogue of
haplotypes to impute the genotypes of all the markers in regions
of interest to test optimally for association between the gene and
the phenotype.
This approach unraveled positive association of CAD with
CXCL12, a gene that maps to 10q11. A CXCL12 intergenic SNP,
rs1746048, had a C-risk allele associated with MI (OR=1.17,
p=7 610
29) [12]. The same rs1746048-C allele yielded positive
association results with CAD in a recent study (OR=1.09,
p=3 610
210) [20]. Although rs1746048 was not associated with
CAD in the Lebanese cohort, another SNP located in the same
LD block, rs7900896, showed positive association results. The two
SNPs are located 59 of CXCL12, 467 Kb away. They are not in the
same HapMap, CEU-based, LD block. Our results imply that this
genomic region contains several causative variants. Whether the
associated SNPs are predisposing by themselves, or whether they
are in LD with the real variant needs further investigations.
Another SNP, rs9295489 in CDKAL1, showed positive associ-
ation with CAD in our cohort. As a part of the Cardiovascular
Health Study (CHS) GWAS that aims to identify genetic variants
associated with cardiovascular risk factors (http://www.ncbi.nlm.
nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000226.v2.
p1), rs2206734 in CDKAL1 was associated with MI occurrence
(p=5.05610
24). The two SNPs are intragenic, 345 Kb away,
defining separate LD blocks. While our study confirms that
variants near CDKAL1 are associated with risk for cardiovascular
anomalies, no published data has associated CDKAL1 with CAD
phenotype. Interestingly, since 2007, numerous studies have
associated CDKAL1 SNPs with a cardiovascular disease (CVD)
risk factor: Type 2 Diabetes (T2D) [19,40,41,42,43]. Thus,
rs9295489 in CDKAL1 may influence T2D levels and consequently
affect the risk for CVD.
Two genes, ST6GAL1 and PTPRD (See Table S1 for positive
SNPs), were shown to be associated with CAD for the first time in
our study. Both genes are known to carry common variants
predisposing to Diabetes Mellitus [18,19,44,45]. Rs16861329 in
ST6GAL1 locus was associated with T2D and pancreatic beta-cell
function [18]. The fact that in our study ST6GAL1 has a protective
effect on CAD occurrence suggests an inverted linkage between
the active alleles or different alleles arising in various impacts on
gene function, and thus, on health. PTPRD, previously shown to
be a susceptibility locus for T2D [19,44,45], carries variants
predisposing to CAD in the Lebanese cohort, showing again a
genetic link between T2D and CAD.
A Bonferroni correction per interrogated marker (20,224) would
be very over conservative since imputation identified many
markers in perfect LD to be tested. A correction for the number
of regions tested (88) would be more appropriate, and would retain
the significance of these results even though these regions can
encompass independent variants. We therefore consider these
candidate genes to be of strong interest, but that they require
further validation.
This association study investigates genetic factors underlying
CAD/MI in individuals of Lebanese ancestry, a population with
increased susceptibility to CAD. We identified common genetic
variants at two loci previously identified as CAD/MI genetic risk
factors (9p21 and CXCL12), and two loci newly associated with
CAD (CDKAL1 and PTPRD). We identified MTHFD1L and
ST6GAL1 as having a protective effect against CAD/MI. Cardio-
vasculardiseasescoexistwith metabolicriskfactorsincludingcentral
obesity and diabetes. Our study provides new insights into the
9p21 Is Associated with Coronary Artery Disease
PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e29427genetic link between metabolic and cardiovascular traits. Some of
the identified loci have implicated metabolic genes without a
previously known connection with CAD. Future studies will build
on these successes by identifying additional variants and by
determining the functional impact of the underlying genes. Further,
our findings show the potential for new discovery from genetic
association studies in populations of non-European ancestry.
Supporting Information
Table S1 Variants’ imputed genotype probabilities.
Imputed genotype probabilities for variants in 88 candidate genes
with +/- 50Kb on each side. The test was considered significant
when P,0.01, relative information .0.4 and minor allele
frequency .5%.
(DOC)
Table S2 Proportional Odds Logistic regression pre-
dicting CAD in graded categories from 10 SNPs.
Proportional Odds Logistic regression predicting CAD in graded
categories from 10 SNPs, both with additive and independent
homozygous/heterozygous odds, without and with adjustment by
family history of CAD, history of smoking, diagnoses of diabetes,
hyperlipidemia, hypertension, and gender are represented. Odds
ratio tests of disease vs. haplotype frequency are also indicated.
(DOC)
Table S3 Logistic regression predicting MI from 10
SNPs. Analysis was performed both with additive and indepen-
dent homozygous/heterozygous odds, without and with adjust-
ment by family history of CAD, history of smoking, diagnoses of
diabetes, hyperlipidemia, hypertension, and gender. Odds ratio
tests of disease vs. haplotype frequency are also represented.
(DOC)
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